TransMedics Group, Inc. TMDX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 57.42% | 111.69% | 251.23% | 436.58% | 181.16% |
| Total Depreciation and Amortization | 52.10% | 45.86% | 43.16% | 31.01% | 39.10% |
| Total Amortization of Deferred Charges | 275.00% | 500.00% | -- | -- | -- |
| Total Other Non-Cash Items | -133.35% | -167.96% | -189.75% | -211.48% | 34.83% |
| Change in Net Operating Assets | -425.35% | 33.29% | 183.88% | 140.84% | 139.98% |
| Cash from Operations | -36.87% | 26.59% | 345.96% | 295.14% | 375.35% |
| Capital Expenditure | -18.00% | 31.69% | 38.84% | 54.33% | 63.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -27.26% | 31.38% | 38.60% | 54.18% | 63.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -25.52% | -38.50% | -21.35% | -25.70% | -33.30% |
| Repurchase of Common Stock | -129.71% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -60.41% | -40.14% | -22.56% | -26.30% | -33.91% |
| Foreign Exchange rate Adjustments | -217.79% | -154.85% | 11,800.00% | 336.94% | 10.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -67.13% | 138.04% | 523.05% | 360.85% | 240.27% |